scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.NUMECD.2010.10.001 |
P953 | full work available at URL | https://openresearch.surrey.ac.uk/view/delivery/44SUR_INST/12139062280002346/13140624680002346 |
https://api.elsevier.com/content/article/PII:S0939475310002334?httpAccept=text/plain | ||
https://api.elsevier.com/content/article/PII:S0939475310002334?httpAccept=text/xml | ||
P698 | PubMed publication ID | 21094028 |
P5875 | ResearchGate publication ID | 49625249 |
P50 | author | Saverio Stranges | Q91987979 |
P2093 | author name string | A. Navas-Acien | |
E. Guallar | |||
M. P. Rayman | |||
P2860 | cites work | Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease | Q24298273 |
Selenoprotein P-expression, functions, and roles in mammals | Q24651837 | ||
Serum selenium and diabetes in U.S. adults | Q27863354 | ||
From selenium to selenoproteins: synthesis, identity, and their role in human health | Q27863358 | ||
The importance of selenium to human health | Q28036749 | ||
Effectiveness of selenium supplements in a low-selenium area of China | Q28611340 | ||
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q29619860 | ||
Selenium and diabetes: an enigma? | Q30319008 | ||
Selenium and coronary heart disease: a meta-analysis | Q33259508 | ||
Selenoproteins and human health: insights from epidemiological data | Q33423296 | ||
Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study | Q33772705 | ||
Serum selenium concentration is associated with metabolic factors in the elderly: a cross-sectional study | Q33863622 | ||
Serum selenium and serum lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. | Q33886602 | ||
Selenium: an insulin-mimetic | Q34160102 | ||
Selenium in global food systems | Q34248778 | ||
Selenoprotein synthesis and side-effects of statins | Q34306983 | ||
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals | Q34370181 | ||
Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells | Q34655573 | ||
Selenium, an antioxidant nutrient | Q34756127 | ||
Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase | Q34827699 | ||
Loss of housekeeping selenoprotein expression in mouse liver modulates lipoprotein metabolism | Q36329021 | ||
Biofortification of UK food crops with selenium. | Q36467467 | ||
Serum selenium and serum lipids in US adults | Q36909586 | ||
Selenium intake and cardiovascular risk: what is new? | Q37057605 | ||
Food-chain selenium and human health: spotlight on speciation | Q37112019 | ||
Food-chain selenium and human health: emphasis on intake | Q37112023 | ||
Serum selenium and peripheral arterial disease: results from the national health and nutrition examination survey, 2003-2004 | Q37306063 | ||
Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells | Q83862214 | ||
Serum selenium and the risk of coronary heart disease and stroke | Q93588339 | ||
Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. | Q37331181 | ||
Serum selenium concentrations and hypertension in the US Population | Q37412394 | ||
Oxidative stress and metabolic syndrome | Q37413526 | ||
Higher selenium status is associated with adverse blood lipid profile in British adults | Q37474793 | ||
Risk of chronic low-dose selenium overexposure in humans: insights from epidemiology and biochemistry | Q37627799 | ||
Too much or too little? A review of the conundrum of selenium | Q37726662 | ||
Serum selenium and coronary heart disease risk factors in southern Italian men. | Q41761406 | ||
Dietary selenium: time to act. | Q42781882 | ||
Interactions of selenium compounds with other antioxidants in DNA damage and apoptosis in human normal keratinocytes | Q43586269 | ||
An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity | Q43658290 | ||
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease | Q43834212 | ||
Selenium and glycogen levels in diabetic patients | Q43856689 | ||
Human erythrocyte hemolysis induced by selenium and tellurium compounds increased by GSH or glucose: a possible involvement of reactive oxygen species | Q43866842 | ||
Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males | Q44250826 | ||
Association of glutathione peroxidase activity with insulin resistance and dietary fat intake during normal pregnancy | Q44690315 | ||
Fibrates but not statins increase plasma selenium in dyslipidemic aged patients--the EVA study | Q46128131 | ||
Oxidation of glutathione and superoxide generation by inorganic and organic selenium compounds | Q46355068 | ||
Molecular mechanisms for hyperinsulinaemia induced by overproduction of selenium-dependent glutathione peroxidase-1 in mice | Q46534639 | ||
Influence of alloxan-induced diabetes and selenite treatment on blood glucose and glutathione levels in mice | Q46556405 | ||
Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study | Q46609785 | ||
Toenail selenium and cardiovascular disease in men with diabetes | Q46644396 | ||
Neurodegeneration in mice resulting from loss of functional selenoprotein P or its receptor apolipoprotein E receptor 2. | Q46825393 | ||
Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice | Q46916732 | ||
Influence of selenium (antioxidant) on gliclazide induced hypoglycaemia/anti hyperglycaemia in normal/alloxan-induced diabetic rats | Q46917544 | ||
Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed. | Q48144238 | ||
Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. | Q53324577 | ||
Blood pressure and blood selenium: a cross-sectional and longitudinal population study | Q56970787 | ||
Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts | Q57315334 | ||
Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death | Q57481354 | ||
Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes | Q58829111 | ||
Intervention trial with selenium for the prevention of lung cancer among tin miners in Yunnan, China | Q67678400 | ||
Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men | Q68092393 | ||
Effect of selenium supplementation after acute myocardial infarction | Q69556385 | ||
Insulin-like vs. non-insulin-like stimulation of glucose metabolism by vanadium, tungsten, and selenium compounds in rat muscle | Q71848012 | ||
Coenzyme Q10 and antioxidants in acute myocardial infarction | Q72243084 | ||
Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study | Q72528718 | ||
An estimation of selenium requirements for New Zealanders | Q73128246 | ||
Spontaneous abortion and exposure to electric blankets and heated water beds | Q74045740 | ||
Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial | Q74420302 | ||
Chemopreventive agents: selenium | Q77425293 | ||
Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus | Q77796656 | ||
A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins | Q79195169 | ||
Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results | Q80156325 | ||
Selenium and diabetes: more bad news for supplements | Q80589704 | ||
Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults | Q80771594 | ||
Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial | Q82635903 | ||
Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial | Q83153938 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | selenium | Q876 |
P304 | page(s) | 754-760 | |
P577 | publication date | 2010-11-20 | |
P1433 | published in | Nutrition, Metabolism, and Cardiovascular Diseases | Q2734631 |
P1476 | title | Selenium status and cardiometabolic health: state of the evidence | |
Selenium status and cardiometabolic health: State of the evidence | |||
P478 | volume | 20 |
Q34428567 | A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin |
Q39094419 | Association of serum concentrations of magnesium and some trace elements with cardiometabolic risk factors and liver enzymes in adolescents: the CASPIAN-III Study |
Q49566654 | Associations Between Selenium Content in Hair and Kashin-Beck Disease/Keshan Disease in Children in Northwestern China: a Prospective Cohort Study |
Q64950520 | Circulating Selenium Concentration Is Inversely Associated With the Prevalence of Stroke: Results From the Canadian Health Measures Survey and the National Health and Nutrition Examination Survey. |
Q34205117 | Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium |
Q49993242 | Dietary pattern associated with selenoprotein P and MRI-derived body fat volumes, liver signal intensity, and metabolic disorders. |
Q57608556 | Distribution and Speciation of Selenium, Antimony, and Arsenic in Soils and Sediments Around the Area of Xikuangshan (China) |
Q46041763 | Effects of nutritional and excessive levels of selenium on red blood cells of rats fed a high cholesterol diet |
Q27301096 | Genome-wide association study of selenium concentrations |
Q28655739 | Histopathological changes due to the effect of selenium in experimental cockerels |
Q38023790 | Impact of dietary selenium intake on cardiac health: experimental approaches and human studies |
Q36941671 | Influence of Gender and SNPs in GPX1 Gene on Biomarkers of Selenium Status in Healthy Brazilians |
Q45803388 | Influence of Selenium: Lemire et al. Respond. |
Q58566113 | Multiple metal exposures and metabolic syndrome: A cross-sectional analysis of the National Health and Nutrition Examination Survey 2011-2014 |
Q34275801 | Oxidative stress is associated with an increased antioxidant defense in elderly subjects: a multilevel approach |
Q37419036 | Plasma selenium levels and nonalcoholic fatty liver disease in Chinese adults: a cross-sectional analysis. |
Q41288553 | Randomised controlled trial of the effect of long-term selenium supplementation on plasma cholesterol in an elderly Danish population |
Q35779103 | Selenium Level and Dyslipidemia in Rural Elderly Chinese |
Q37640141 | Selenium and Thyroid Disease: From Pathophysiology to Treatment |
Q90318703 | Selenium and large artery structure and function: a 10-year prospective study |
Q36866303 | Selenium and maternal blood pressure during childbirth |
Q33647386 | Selenium exposure and depressive symptoms: the Coronary Artery Risk Development in Young Adults Trace Element Study |
Q38778791 | Selenium in the prevention of atherosclerosis and its underlying mechanisms. |
Q37708940 | Selenium levels and hypertension: a systematic review of the literature |
Q35211152 | Selenium status and blood lipids: the cardiovascular risk in Young Finns study. |
Q24201670 | Selenium supplementation for the primary prevention of cardiovascular disease |
Q24203785 | Selenium supplementation for the primary prevention of cardiovascular disease |
Q35081947 | Selenium suppresses oxidative-stress-enhanced vascular smooth muscle cell calcification by inhibiting the activation of the PI3K/AKT and ERK signaling pathways and endoplasmic reticulum stress |
Q36994043 | Selenium toxicity from a misformulated dietary supplement, adverse health effects, and the temporal response in the nail biologic monitor |
Q46740173 | Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models |
Q92570030 | Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death |
Q50192080 | Selenoproteins and cardiovascular stress |
Q26767127 | Systematic review of zinc biochemical indicators and risk of coronary heart disease |
Q34663675 | The association between selenium and lipid levels: a longitudinal study in rural elderly Chinese |
Q26827989 | The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities |
Q52740209 | Trace minerals intake: Risks and benefits for cardiovascular health. |
Q38137010 | Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease |
Q46897420 | XAS and XFM studies of selenium and copper speciation and distribution in the kidneys of selenite-supplemented rats |
Search more.